At a glance
- Originator Aventis
- Class Antidementias; Neuroprotectants
- Mechanism of Action GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 18 May 1995 Discontinued-Preclinical for Cognition disorders in Italy (Unknown route)